Form 4: Bausch Health CFO Disposes Shares for Tax Obligations

Bausch Health Companies Inc. EVP and CFO Jean-Jacques Charhon disposed of 49,060 common shares to cover tax obligations from vested Restricted Share Units.

Summary

• Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer of Bausch Health Companies Inc., reported a transaction on February 27, 2026.
• The transaction involved the disposition of 49,060 common shares, no par value, of Bausch Health Companies Inc.
• These shares were withheld by the Issuer to satisfy tax withholding obligations due upon the vesting of Restricted Share Units.
• The disposition occurred at a price of $5.93 per share.
• Following this transaction, Jean-Jacques Charhon directly beneficially owns 706,478 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a routine, non-discretionary transaction related to executive compensation and tax obligations, providing no new insights into the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that the disposition of shares to cover tax withholding obligations upon the vesting of Restricted Share Units is a common and routine event for executives receiving equity-based compensation across various industries. This type of transaction is a standard part of executive compensation plans and tax planning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction and not a discretionary sale indicating a change in executive sentiment or company fundamentals.
• Employees: No direct impact on the broader employee base is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares by an executive upon the vesting of Restricted Share Units. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a standard part of executive compensation and tax planning, and therefore, a 'hold' recommendation is maintained as there are no new fundamental drivers for a change.

Keywords

Bausch Health, BHC, Form 4, Insider Transaction, Share Disposition, Tax Withholding, Restricted Share Units, Executive Compensation